Weight & Metabolic

Tirzepatide

Dual-incretin therapy, managed like a medical program.

Dual GLP-1 & GIP Therapy
Advanced Metabolic Support
Provider-Guided Titration

Starting at $239/month

Multidose kit · 3 mo · 1 Kit$589
Multidose kit · 6 mo · 1 Kit$1,074
Multidose kit · 12 mo · 1 Kit$1,788
Single dose · 2.5 mg · 1 mo · 1 Each$239
Single dose · 5 mg · 1 mo · 1 Each$239
Single dose · 7.5 mg · 1 mo · 1 Each$239
Single dose · 10 mg · 1 mo · 1 Each$239
Single dose · 12.5 mg · 1 mo · 1 Each$239
Single dose · 15 mg · 1 mo · 1 Each$239

Talk to a Provider

Prescription only where clinically appropriate, following provider evaluation.

Form & cadence

Injectable · Weekly

Investment

Personalized plans are shared after provider review. Pricing varies by therapy and treatment plan, and medication cost is disclosed transparently before you commit.

Overview

A dual GIP/GLP-1 protocol that may produce deeper metabolic remodeling than GLP-1 monotherapy in appropriate candidates, prescribed under continuous provider oversight and paired with structured lifestyle support.

Tirzepatide is the first approved dual GIP/GLP-1 receptor agonist. In outpatient care it has demonstrated some of the most substantial weight and metabolic effects of any pharmacologic option to date — provided the plan around it is patient, individualized and monitored.

How it works

The mechanism

Simultaneous activation of GIP and GLP-1 pathways augments insulin sensitivity, satiety signaling and adipose handling, producing complementary metabolic effects that GLP-1 activity alone does not fully cover.

Candidacy

Who it's for

—Adults seeking more depth of metabolic response than GLP-1 monotherapy has provided
—Patients able to commit to lab-monitored, provider-guided titration
—Those looking for a plan that includes maintenance and de-escalation from day one

Benefits it may support

What good care can do.

Individual response varies. Our providers define realistic outcomes with you before any protocol begins, and refine the plan as your body responds.

—May support meaningful, sustained weight reduction in appropriate candidates
—Designed to help improve glycemic control and insulin sensitivity
—May reduce visceral adiposity and cardiometabolic risk markers over time
—Personalized protocol paired with nutrition and resistance-training guidance

What to expect

A calibrated timeline.

After your assessment, our provider reviews your history and, where indicated, orders baseline labs. If tirzepatide is clinically appropriate, your personalized protocol is prescribed and shipped discreetly. From there, care is continuous — with scheduled check-ins, adjustment where needed and ongoing medical oversight throughout your plan.

Weeks 1–8

Careful dose escalation; early appetite and glycemic shifts.

Months 3–6

Composition changes and cardiometabolic markers typically consolidate.

Safety & side effects

Responsibly prescribed.

The GI profile mirrors semaglutide, generally proportional to dose. Titration is the entire game. Contraindications match the wider GLP-1 class.

This is a summary, not a complete list of considerations. Your provider will review the full risk-benefit picture, personal and family history, current medications and contraindications before any protocol is prescribed.

Provider oversight

Care that continues.

Every protocol is prescribed and managed by a US board-certified provider. Dose adjustments, ancillary medications, laboratory cadence and de-escalation decisions are made by your provider, not by a template.

Secure messaging keeps the conversation open between visits. When labs or symptoms suggest a change, we adjust. When a protocol has done its work, we say so.

Questions